| Ticker Symbol: | FRX |
|---|---|
| Exchange: | NYSE |
| Contact Info: | 909 Third Avenue New York NY 10022-4731 212-421-7850 |
| CEO/President: | Howard Solomon |
| Industry: | Medical - Drugs / Standard Industry Code: 2834 |
| Description: | Forest Laboratories, Inc. and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician\'s prescription, as well as non-prescription pharmaceuticalproducts sold over-the-counter. Forest\'s most important United Statesproducts consist of branded ethical drug specialties marketed directly, or to physicians by the company\'s Forest Pharmaceuticals, Forest Therapeutics and Forest Specialty Sales salesforces. |
| Shares Outstanding: | 304,870 (000) | Market Value: | 7,002,770 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 92.36% | Number of Inst.Shareholders: | 2.66% |
| Last Quarter Sales: | 992.51 ($Mil.) | Last Quarter Net Income: | 244.09 ($Mil.) |
| Last Quarter EPS: | 0.80 | P/E Ratio: | 7 |
| Most Recent Earnings: | 0.80 on 10/21/08 | Earnings Per Share: | 3.10 |
| Most Recent Split: | 2-1 on 01/09/03 | Annual Dividend Rate: | 0 |
| Most Recent Dividend: | Annual Dividend Yield: | 0% |


| PFIZER INC | -27.40 | 16.28 | |
| JOHNSON AND JOH | -12.30 | 60.05 | |
| BRISTOL MYERS S | -24.60 | 19.58 | |
| SCHERING PLOUGH | -42.50 | 15.76 | |
| MERCK CO INC | -52.80 | 27.33 |
